Here we provide articles of interest in our field of expertise.

Allergan recalls BIOCELL Textured Breast Implants and Tissue Expanders

Allergan has voluntarily withdrawn all BIOCELL Textured Breast Implants and Tissue Expanders from the worldwide market.

Healthcare providers should now no longer implant these products and unused items should be returned to Allergan. This followed a request from the US FDA, which was based on new data. There is no recommendation to remove or replace textured breast implants from patients without symptoms.

The global recall does not affect Allergan's NATRELLE smooth or MICROCELL breast implants and tissue expanders.

UK regulator looks at safety of implants

"A link to biofilm is not yet generally recognised, largely because the organisms are hard to grow. Special methods are needed to grow them, which is seldom done. We have found that the offending organisms are usually from three differing bacterial  varieties. This explains why so many feel  so much  better after having the implants removed as the home for the organisms is on the inside of the capsule next to the implant and this is removed completely and the organisms with it. We are accumulating the data and will report." David Crabb, surgeon.

Plastic surgeons warn of risk of implants

Australian and New Zealand plastic surgeons have been at the forefront of research into breast implant associated anaplastic large cell lymphoma (BIA-ALCL).

A joint Australian and New Zealand task force was formed in 2015 with representation from ASAPS, ASPS, NZAPS, Haematology and the Australian Breast Device Registry.

Click here>> to find out more.


Are breast implants triggering cancer?

Channel 9 in Australia  has produced a story about the risk of implants - Are breast implants triggering cancer? New Australian research reveals disturbing risk to women

Click here>> to view